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Abstract
Study Design: This was an epidemiological study using national administrative data from the MarketScan database.
Objective: To investigate the impact of early versus delayed adjuvant radiotherapy (RT) on wound healing following surgical
resection for spinal metastatic disease.
Methods:We queried the MarketScan database (2007-2016), identifying patients with a diagnosis of spinal metastasis who also
underwent RT within 8 weeks of surgery. Patients were categorized into “Early RT” if they received RT within 4 weeks of surgery
and as “Late RT” if they received RT between 4 and 8 weeks after surgery. Descriptive statistics and hypothesis testing were used
to compare baseline characteristics and wound complication outcomes.
Results: A total of 540 patients met the inclusion criteria: 307 (56.9%) received RT within 4 weeks (Early RT) and 233 (43.1%)
received RT within 4 to 8 weeks (Late RT) of surgery. Mean days to RT for the Early RT cohort was 18.5 (SD, 6.9) and 39.7 (SD,
7.6) for the Late RT cohort. In a 90-day surveillance period, n ¼ 9 (2.9%) of Early RT and n ¼ 8 (3.4%) of Late RT patients
developed wound complications (P ¼ .574).
Conclusions: When comparing patients who received RT early versus delayed following surgery, there were no significant
differences in the rates of wound complications. Further prospective studies should aim to identify optimal patient criteria for
early postoperative RT for spinal metastases.
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Introduction
Broadening indications for surgical management such as neu-
rological deterioration, spinal instability, and mechanical back
pain have increased the role of surgical resection in the man-
agement of patients with spinal metastases.1,2 The landmark
study by Patchell et al3 established a clear role for surgical
decompression for spinal metastases, and several studies fol-
lowing have demonstrated the clinical benefit and cost effec-
tiveness of surgery with adjuvant radiotherapy (RT) when
compared with RT alone.2-5
However, wound healing complications may arise when
administering adjuvant RT.5-7 Previous reports have indicated
RT dose- and frequency-dependent wound breakdown in early
postoperative patients.8-10 This may be further exacerbated by
the cachexic nature of many patients undergoing concurrent
chemotherapy.10 Given the lack of guidelines on optimal post-
operative RT timing, the decision is often left to the physician’s
discretion, with a need to balance enough time post-operatively
for wound healing with a need for RT to limit tumor
progression.11,12
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The aim of the current study is to compare the rates of
wound complications in patients undergoing early or delayed
RT following surgical resection of spinal metastatic disease.
We hypothesize that the rates of wound complications will vary
between the cohorts, and that patients receiving RT with a
longer healing period following surgery will have lower rates
of wound complications.
Methods
Data
We obtained a sample of the MarketScan Commercial Claims
and Encounters database (Truven Health Analytics, Ann Arbor,
MI) from January 1, 2007 to December 31, 2016. This database
is a collection of commercial inpatient, outpatient, and phar-
maceutical claims of more than 75 million employees, retirees,
and dependents representing a substantial portion of the US
population covered by employer-sponsored insurance. The
MarketScan database contains International Classification of
Diseases, 9th Revision, Clinical Modification (ICD-9-CM) and
10th revision, Clinical Modification (ICD-10-CM), Current
Procedural Terminology (CPT), Diagnosis Related Group
(DRG) codes, as well as National Drug Codes (DEA).
Sample
A total of 1054 patients with a central nervous metastasis were
identified via ICD-9 codes (198.3-198.5) and an associated
CPT code for either laminectomy for tumor resection
(63 275-63 278, 63 290) or corpectomy for tumor resection
(63300-63 303; 63101-63102). Patient records were then quer-
ied to identify patients who underwent RT within 8 weeks of
surgery via stereotactic radiosurgery (CPT codes 77 435,
77373, 63620, 63621) or external beam 3-dimensional (3D)
conformal radiation therapy (CPT codes 77 301, 77 385,
77386). Patients were categorized into 2 cohorts: early RT if
RT was delivered within 4 weeks of surgery, or late RT if
delivered between weeks 4 to 8 following surgery. A majority
of patients initiated RT within 8 weeks of surgery, and the
4 week cutoff allowed for comparable cohorts to be analyzed.
The RT window of 8 weeks was chosen because a vast majority
of patients initiated RT in this interval after surgery. The dis-
tribution of patients receiving RT during this time was approx-
imately split at the 4-week mark, which was the rationale
behind making 4 weeks the cutoff for Early vs Late RT.
Patients younger than 18 years or with ICD-9-CM codes con-
sistent with trauma (N ¼ 301) were excluded. A final cohort of
N ¼ 540 patients was analyzed (Figure 1).
Outcomes and Variables
The primary outcome of this study was development of a
wound complication following adjuvant radiation therapy and
index surgery. Wound complication was defined by the follow-
ing ICD-9-CM codes: wound infection (998.5, 998.51998.59),
wound dehiscence (9983, 99 830, 99 831, 99 832), wound
hematoma (9981, 99 811, 999 812, 99 813) or unspecified
wound complication (998.8, 99 881, 99 883, 9984, 9989).
Patients were stratified not only by early or late RT, but also
by surgical type and patient characteristics. Patient-level vari-
ables, including age at diagnosis, sex, geographic region, insur-
ance plan type, and quality and cost metrics, were taken
directly from the claims data. Complications and primary
tumor type were assessed using ICD-9-CM codes.
Analyses
Two-sample t-tests and chi-square tests were utilized to assess
significant differences in demographic data, primary tumor
source of the spinal metastasis, postoperative complications,
quality outcomes, and payments among the groups. P values
were interpreted as significant only after applying the Bonfer-
roni correction for multiple comparisons.
Ethical Considerations
All data from these databases was de-identified, and thus this
study is exempt from institutional review board approval in
accordance with the Health Insurance Portability and Account-
ability Act of 1996.
Results
Patient Cohort and Baseline Characteristics
A total of 540 patients met the inclusion criteria of this study, of
which 307 (56.9%) received RT within 4 weeks (“early”) and
Figure 1. Cohort diagram.
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233 (43.1%) received RT within 4 to 8 weeks (“late”) of sur-
gery (Table 1, Figure 2). Mean days to radiation therapy were
18.5 (SD 6.9) in the Early RT cohort and 39.7 (SD, 7.6) in the
Late RT cohort (P < .002). Mean age was 52.6 years (SD, 9.7)
in the Early RT patients, and 53.0 years (SD, 10.1) in the Late
RT patients. Rates of hypertension, diabetes, and chronic
obstructive pulmonary disorder (COPD) between Early and
Late RT groups were similar. Lung and breast cancer were the
primary malignancies in this study accounting for 11.4% and
10.4% of patients in the Early RT cohort, respectively, and
9.0% and 9.8% in the Late RT cohort, respectively (P ¼ .45,
P ¼ .53, respectively).
Rates of preoperative chemotherapy were greater in the
group receiving early RT (21.2% vs 20.6% in Late RT;
P > .05). Patients undergoing Late RT had higher rates
of combined anterior-posterior procedures (9.4% vs 3.9%;
P ¼ .01). The use of spinal instrumentation was similar in both
groups (34.2% Early, 39.5% Late; P ¼ .24). Modality of RT
delivery was significantly different among groups, with
patients undergoing early RT more likely to receive 3D con-
formal external beam radiation (3DCRT) and patients under-
going late RT more likely to receive stereotactic radiosurgery
(SRS): 86 patients (28.0%) in the early RT group received SRS
and 100 patients (42.9%) in the late RT group received SRS (P
< .002). 3DCRT was used in 221 (72.0%) of Early RT patients,
and 133 (57.1%) of late RT patients (P < .002).
Wound Complication Rates of Early Versus Late RT
Wound-complication free duration is described for both
cohorts in Figure 3. The rate of wound complication within
90 days was not significantly different between groups (Early
RT 2.9%, late RT 3.4%; P ¼ .574). Furthermore, there were no
significant differences in age, gender, neurological status, type
of surgery, type of radiation, and use of preoperative che-
motherapy, in patients who developed wound complications
versus patients that did not (Table 2).
Discussion
Given the increasing role of combined surgery and RT for the
management of spinal metastases, the optimal treatment timing
is of significant interest. Guidelines have been created regard-
ing optimal dosing and type of RT for spinal metastases based
on numerous pathologic features; however, given concerns for
wound deterioration, clear strategies for the timing of post-
operative RT remain unknown.11,13 This study utilized a novel
dataset to conduct a comparative analysis of patients under-
going surgery and RT for metastatic disease of the spine from
2007 to 2016. Patients were categorized by the timing of RT
following surgery: Early RT (delivered within 4 weeks after
surgery) or Late RT (delivered between 4 and 8 weeks after
surgery). Baseline characteristics, comorbidities, primary
tumor type, surgical strategies were similar among cohorts.
Although a majority of both cohorts received external beam
RT, rates differed significantly between the early and late RT
Table 1. Demographics and Treatment Characteristics of Patients
With Spinal Metastases.
Early
Radiotherapy
(N ¼ 307)
Late
Radiotherapy
(N ¼ 233)
n % n % P
Female 122 39.7 97 41.6 .72
Age, years, mean (SD) 52.6 (9.7) 53.0 (10.1) .41
Comorbidities
Hypertension 87 28.3 70 30.0 .74
Diabetes 58 18.9 55 23.6 .22
COPD 60 19.5 44 18.9 .93
Primary malignancy
Lung 35 11.4 21 9.0 .45
Breast 33 10.7 30 9.8 .53
Renal 26 8.5 18 5.9 .88
Prostate 27 8.8 18 5.9 .77
Melanoma 15 4.9 8 2.6 .54
Colorectal 13 4.2 7 2.3 .60
Thyroid 3 1.0 7 2.3 .11
Other 155 50.5 124 40.4 .59
Preoperative
chemotherapy
65 21.2 48 20.6 .96
Myelopathy at
presentation
124 40.4 81 34.8 .21
Surgical characteristics
Laminectomy 264 86.0 185 79.4 .06
Corpectomy 31 10.1 26 11.2 .80
Combined 12 3.9 22 9.4 .01
Instrumentation 105 34.2 92 39.5 .24
Adjuvant radiotherapy
Stereotactic 86 28.0 100 42.9 .0004
External beam 221 72.0 133 57.1 .0004
Time to radiotherapy,
days, mean (SD)
18.5 (6.9) 39.7 (7.7) .0001
Outcome
Wound complication 9.0 2.9 8.0 3.4 .574
Figure 2. Timing of adjuvant radiotherapy following surgery for spinal
metastasis.
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groups (Early RT 72.0%, Late RT 57.1%; P ¼ .0004). This
study found no significant difference in the rate of wound
complications between the 2 cohorts within 90 days of RT
(P ¼ .574).
Early wound healing following surgery is characterized by 2
stages—inflammatory and proliferative. The inflammatory
stage occurs 0 to 4 days following surgery, whereas the pro-
liferative stage extends from days 2 to 21 after surgery. This
early phase of healing constitutes migration and proliferation of
inflammatory cells, and further proliferation of collagen-
producing fibroblasts. Radiation during the inflammatory stage
has been shown to diminish hyperplasia of inflammatory cells
and inhibit deposition of collage during the proliferative
stage.14,15 Granulation, which occurs approximately a week
after surgery, is less radiosensitive.8 However, the preclinical
and clinical data supporting this is inconsistent. Devereux
et al16 noted that wound complications rates were similar in
rats irradiated after 1 week and those who were not irradiated at
all. Another preclinical study found that RT could be more
aggressively administered safely, and a 1- to 2-day window
following surgery is adequate.17 A study by Laocharoensombat
et al18 found that 7.1% (n ¼ 1) patients undergoing RT 14 days
after surgery for epidural metastases developed wound compli-
cations. Finally, a study by Onimus et al in a similar cohort
showed that none of their patients (0/16) developed a wound
complication when treated with RT 7 days following sur-
gery.19,20 Our findings echo much of these clinical data and
indicate that early RT does not increase the risk of wound
complications following resection of a spinal metastasis.
The mechanism of radiation delivery has also been impli-
cated in wound complication development. Postoperative SRS
may be a safer option than conventional, external beam radia-
tion, with respect to development of a wound complica-
tion.14,21-26 However, our study did not find an association of
radiation type with wound complications. This may be due to
patient selection by the treating physician, where 3DCRT was
not performed in patients clinically deemed to be at higher risk
of a wound breakdown.
Several patient level and operative characteristics have been
implicated as risk factors for wound complications following
spine surgery. Patient age,27,28 obesity,29-31 tobacco use,32 poor
nutritional status,28,32 nonsteroidal anti-inflammatory drug
(NSAID) use,33 and high baseline comorbidity burden have
been associated with postoperative wound complication.34 Pos-
terior surgical approach, tumor resection, revision surgery,34
increased estimated blood loss (EBL),35 longer operative time,
multilevel fusion, and instrumentation29 may also increase the
risk of wound dehiscence, superficial surgical site infection
(SSI), deep SSI, or organ space SSI. Although the initial studies
that identified these risk factors were limited by their small
sample sizes, more recent large studies using national data-
bases and multivariate regression have corroborated much of
these findings.36,37 Many of these risk factors are not modifi-
able; however, they help in surgical planning and identifying
patients that may benefit from prophylactic antibiotics. There is
also a significant financial burden associated with postopera-
tive wound complications—with neurosurgical SSIs contribut-
ing to a $23755 per case increase compared with nonwound
complication cases.38 Wound complications have also been
associated with increased mortality and readmission rates, and
longer length of stays—making it exceedingly important for
spine surgeons to prevent these.39
Limitations
The main limitations of this study are due to the inherent flaws
of the MarketScan administrative dataset. We assumed
Figure 3. Kaplan-Meier curves for time to wound complication,
stratified by radiotherapy timing.
Table 2. Characteristics of Patients With Wound Complications
Following Adjuvant Radiotherapy.
Wound
complication
(N ¼ 17)
Control
(N ¼ 523)
n % n % P
Female 11 64.7 208 39.8 .07
Age, years, mean (SD) 50.3 (11.3) 52.9 (9.8) .28
Preoperative
chemotherapy
2 11.8 111 21.2 .52
Myelopathy at
presentation
3 17.6 202 38.6 .13
Surgical characteristics
Laminectomy 15 88.2 434 83.0 .81
Corpectomy 1 5.9 56 10.7 .81
Combined 1 5.9 33 6.3 1.00
Instrumentation 6 35.3 191 36.5 1.00
Adjuvant radiotherapy
Stereotactic 7 41.2 179 34.2 .74
External beam 10 58.8 344 65.8 .74
Time to radiotherapy,
days, mean (SD)
27.8 (9.5) 27.6 (12.9) .90
4 Global Spine Journal
accuracy of all diagnosis and procedure codes in the database.
In particular, we relied on the codes to identify the presence of
wound complications, and this may have led to underestima-
tion of true wound complication rates. Furthermore, this study
was unable to assess overall tumor burden or extent of tumor
progression, factors that could influence RT timing. Addition-
ally, we are unable to determine the size of the wound in each
group, and larger incisions could predispose patients to wound
breakdown.
As previously mentioned, there are several other factors that
may influence the rates of wound complications outside the
timing of RT initiation that may confound these results.
Because of the low incidence of wound complications, the
study was underpowered and we could not conduct a propen-
sity score match or logistic regression to control for the con-
founders, a limitation of our statistical findings. Further
prospective studies are required to examine the impact of these
factors. This study also does not answer the question as to
whether there is an optimal timing of radiation therapy within
the early 4-week postoperative window. The 4-week stratifica-
tion of Early RT was arbitrary, and does not inform us of a
more specific optimal time for adjuvant RT.
Conclusions
When comparing patients who received RT early vs delayed
following surgery, there were no significant differences in the
rates of wound complications, suggesting that adjuvant RT can
be commenced within 4 weeks of surgery with an acceptable
complication rate. Further prospective studies should aim to
identify optimal patient criteria for early postoperative RT for
spinal metastases.
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